Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06989489 · ClinicalTrials.gov registry record · NA
Implementation of an Oral Chemotherapy Adherence Intervention
A NA study of Solid Tumor and Hematologic Malignancy, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT06989489 is a NA study of Solid Tumor and Hematologic Malignancy that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 160 participants, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06989489, a NA study of Solid Tumor and Hematologic Malignancy, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to evaluate the effectiveness and usability of a newly developed oral anticancer agent adherence program implemented across 6 cancer clinics (two academic, two urban, and two rural). The study will include 160 adult participants with either solid tumors or hematologic malignancies who have been taking oral anticancer agents for at least six months. This study will have two groups of participants, a pre- and post-implementation group. In the pre-implementation of the program group, investigators will administer a survey to the 80 participants and gather information about their medication prior to their enrollment of the program. Similarly, 80 participants who have been enrolled into this program for at least 6 months will serve as the post-implementation group. These patients will be administered the same survey. The results from both groups will be analyzed to see how effective the medication adherence program is.
Conditions Studied
Interventions
- BEHAVIORAL Multilevel Adherence Intervention
Study Locations (1)
North Carolina
- UNC Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2025-05-28 |
| Est. Completion | 2028-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06989489
The ClinicalTrials.gov registry entry for NCT06989489 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (28% lower). The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which Multilevel Adherence Intervention is the first listed.
NCT06989489 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06989489 about?
NCT06989489 is a clinical study titled "Implementation of an Oral Chemotherapy Adherence Intervention". The goal of this study is to evaluate the effectiveness and usability of a newly developed oral anticancer agent adherence program implemented across 6 cancer clinics (two academic, two urban, and two rural). The study will include 160 adult participants with either solid tumors or hematologic malig...
What is the current status of trial NCT06989489?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-05-28. Estimated completion is 2028-08-30.
What conditions does trial NCT06989489 study?
This clinical trial studies the following conditions: Solid Tumor, Hematologic Malignancy.
What interventions are being tested in trial NCT06989489?
The interventions under investigation include: Multilevel Adherence Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06989489?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06989489 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
RECRUITING · NA
-
Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
RECRUITING · NA
-
High Dose Re-Irradiation Utilizing Advanced Deformable Image Registration (DIR) and Individualized Organ At Risk (OAR) Dose Calculations With Organ Specific Toxicity Analysis
RECRUITING · NA
-
Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy
RECRUITING · NA
-
Psychotherapy Intervention for Latinos With Adv Cancer
RECRUITING · NA
-
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.